Purpose. Examine the bene® ts and limitations of ® ne-needle aspiration cytology (FNA) used as the de® nitive diagnostic m ethod before treatment. M eth od. Review of the 25 year experience at a multidisciplinary musculo-skeletal centre where FNA is the prim ary diagnostic approach to soft tissue sarcoma in the extremities and trunk wall and the experience of various experts in the ® eld.
Introduction
O pen surgical biopsy or coarse needle biopsy are w idely considered to be the diagnostic procedures necessary before the de® nitive treatm ent of a soft tissue sarcom a. F ine-needle asp iration and cytodiagnosis (FN A) has not been universally accepted as a pretreatm ent diagnostic m ethod although num erous reports on the use of F N A in the diagnosis of soft tissue tum ours have been published during the last 20 years. 1± 6 T he subsequent review on the bene® ts and lim itations of FN A as the de® nitive diagnostic m ethod of soft tissue sarcom a before treatment is based on a 25 year experience of FN A of soft tissue tum ours in the extremities and trunk wall from the m ultidisciplinary M usculo-Skeletal T umour C entre at the University H ospital, Lund as well as on cited references.
B ene® ts of FNA
F N A offers several advantages com pared w ith open as well as coarse needle biopsy. FN A of soft tissue tum ours is a harmless out-patient procedure. Severe com plications are non-existent; at m ost there is a tenderness for some days after the needling and a local haem orrhage. Anaesthesia and hospitalization are not necessary. In children, a short general anaesthesia m ay be needed, depending on the clinical presentation of the tumour. W hen the aspirations are perform ed by cytopathologists it is easy to perform a rapid staining of the ® rst sm ear and within 10± 15 m inutes ensure that the m aterial is suf® cient and diagnosable and to suggest a prelim inary diagnosis. Further investigations and/or suggested treatm ent can then be discussed with the patient at the ® rst visit, which is im portant when patients are referred from other hospitals. Properly perform ed FN A is the least tissue-invasive diagnostic procedure and the risk for sarcoma-cell spread is negligible. Com pared with coarse needle biopsy, which is also an out-patient procedure, a rapid prelim inary report is easier to render as well as the sam pling of tum our m aterial from different parts of large tum ours in order to diagnose tum our heterogeneity, w hich can provide im portant diagnostic inform ation (Fig. 1) . The econom ical bene® ts are not only due to reduced costs for hospitalization and the use of an operating room, but the num ber of patient visits is also reduced.
The m ost im portant objections against the use of F N A as the de® nitive diagnosis of soft tissue tum ours in general is the proposed inability for the cytopathologist to give a reliable histotype diagnosis and m alignancy grade. 7, 8 The bene® ts and lim itations of FN A in the de® nitive diagnosis of a soft tissue sarcom a m ust, however, be related to the proposed treatment. W hen prim ary surgery is considered, the surgeon m ust have a reliable diagnosis of sarcom a. T he type of surgery perform ed depends m ore on the site and size of the sarcom a and its relation to vessels, nerve bundles and periosteum than on the histogenetic type. T hus with this treatm ent m odality the cytopathologist m ust be able to exclude other malignancies as soft tissue m etastases and prim ary soft tissue m alignant lym phom a and to differentiate between benign soft tissue tum ours/ lesions and sarcoma. O n the other hand, when the treatment option is neoadjuvant therapy followed by surgery, the FN A diagnosis m ust equal that of a biopsy or coarse needle specim en w ith regard to speci® c sarcoma type and m alignancy grade.
P rim ary surgery of soft tissue sarcom a
At present the ® ne-needle asp iration cytology of num erous benign soft tissue tumours/lesions as well as soft tissue sarcom a histotypes have been investigated and diagnostic criteria suggested (Table 1) . One important group of lesions in which the bene® ts of FN A are well docum ented is in the diagnosis of the various pseudosarcom atous soft tissue lesions (nodular fasciitis, proliferative fasciitis and m yositis and pseudom alignant m yositis ossi® cans). The clinical presentation of these lesions is often suspicious for m alignancy; rapid growth, ® rm at palpation and ® xed to underlying structures and biopsy specim ens or excised lesions have been m isinterpreted as sarcom a. The F N A cytology of these lesions has been thoroughly studied. 9± 12 It has also been docum ented that the need for surgical intervention m ost often is unnecessary as the also been docum ented that the need for surgical intervention m ost often is unnecessary as the m ajority of these tumour-like lesions disappe ar completely or greatly dim inish in size some weeks after the needling. 11, 13, 14 The cytologic app earance in FN A sm ears of the m ost com m on sarcomasÐ pleom orphic sarcom a of the MF H-type, myxo® brosarcom a (Fig. 2) , m yxoid, round cell and pleom orphic liposarcom a (Fig. 3) , leiom yosarcom a (Fig. 4) and synovial sarcom aÐ has been described in various series of correlative cytologic± histologic studies. 15± 22 Less frequent sarcom as such as clear cell sarcom a, alveolar soft part sarcom a, rhabdom yosarcom a and (extraskeletal) Ew ing' s sarcom a/PN ET (peripheral neuroectoderm al tumour) have also been characterized in F N A m aterial. 23± 28 There is a num ber of sarcom a entities which are insuf® ciently characterized in FN A, am ong them especially m alignant vascular tum ours. It is often possible, however, to give a con® dent sarcom a diagnosis in these cases, the evaluation of m alignancy based on the sm ear pattern, the uniform or pleom orphic cytologically m alignant cell population, num erous m itotic ® gures and fragm ents of necrotic tum our tissue.
Neoadju vant therap y follow ed by surgery
At present, neoadjuvant therapy is considered in the sm all round cell sarcom as such as rhabdom yosarcom a, extraskeletal Ewing' s sarcom a, PNE T, and synovial sarcoma and in selected large, deep-seated high-grade m alignant soft tissue sarcoma of various histotypes.
W hen neoadjuvant therapy (radiotherapy or chem otherapy) is part of the de® nitive treatment, the cytodiagnosis m ust include a con® dent histotype diagnosis and in cases of preoperative radiotherapy of deep-seated sarcom a also a reliable m alignancy grading. Cytologic m alignancy grading of soft tissue sarcom a into low or high grade is possib le and is based on the evaluation of cellular and nuclear pleom orphism and atypia, m itotic activity, especially the presence of atypical m itoses, and necrosis. The histogenetic type of a sarcom a m ight also be im portant in the decision of m alignancy grade, for exam ple, pure m yxoid liposarcom a is m ost often a low-grade tum our while synovial sarcom a is high-grade. According to our experience a reliable m alignancy grading into low or high grade m alignant sarcom a is possib le to perform in about 75% of sarcom as needled. 29 The cytologic features of rhabdom yosarcom a, Ew ing' s sarcoma, PN ET , and synovial sarcom a in F N A sm ears have been studied and diagnostic criteria de® ned. Although these criteria may be the basis of a con® dent type-diagnosis the cytologic exam ination should be supplem ented with various ancillary diagnostic m ethods. In F N A aspirates it is possib le to m ake use of the same supplementary techniques as in surgical specim ens and the use of adjunctive diagnostic m ethods in FN A is well docum ented. 25 , 30± 34 At present routine cytologic exam ination combined with ancillary diagnostics successfu lly and reliably can diagnose m ost sm all round cell sarcom as and synovial sarcom as before the neoadjuvant therapy. In m any pleom orphic high-grade sarcom as it is also possible to de® ne the histotype.
Lim itations of FNA
T he lim itations of FN A in the diagnosis of soft tissue sarcom a are threefold: (a) the sarcom a is not hit with the needle and a false diagnosis m ay be rendered on the reactive cellular changes in the aspirated surrounding tissues; (b) insuf® cient m aterial (poor yield or technically inferior sm ears) from the tum our is evaluated; and (c) m isinterpretation of the aspirated cells. According to our 25 year experience one im portant reason for a false diagnosis is that the m aterial exam ined does not originate from the sarcoma but from the surrounding tissues. In these cases either a benign diagnosis is given or a false sarcom a-type diagnosis is suggested, based on reactive, pseudom alignant cellular changes, especially reactive changes in adipose tissue resem bling liposarcom a or reactive pleom orphic ® broblasts and m yo® broblasts falsely interpreted as originating from a m alignant ® brous histiocytoma. T his is m ost often the case with small deep-seated, inter-or intram uscular sarcom as.
The m ain reason for a false diagnosis is, however, m isinterpretation of the cellular m aterial. T here is a num ber of w ell-docum ented diagnostic dif® culties. O ne of the m ost com m on is the correct evaluation of tumours predom inantly com posed of spindle cells 2, 35, 36 ( Figs 5 and 6 ). Another im portant pitfall is false m alignant diagnosis of benign lipoma variants as pleom orphic and spindle cell lipom a, hibernom a and lipoblastom a.
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A rare diagnostic dif® culty is the m isinterpretation of aspirates from soft tissue m etastases from pleom orphic carcinom a 
D iscussion
T he clinical bene® ts of FN A in the prim ary, de® nitive diagnosis of soft tissue sarcom a are advantageous, but to reach a reasonably high diagnostic accuracy certain requirem ents should be observed. A close co-operation between the surgeon and cytopathologist is m andatory. The surgeon often w ill decide the insertion point of the needle and when demanding a prelim inary report, discuss the diagnosis w ith the cytopathologist in relation to the clinical history, palpatory ® ndings and radiograph ic investigations, if any. T he ® nal diagnosis should be the com bined evaluation of clinical and radiograph ic data and the cytodiagnosis. In order to avoid false diagnoses due to a faulty asp iration technique and inability to hit the tumour at needling the cytopathologist m ust be a trained aspirator with a fair knowledge of the clinical behaviour and histopathology of soft tissue tum ours. Ultrasound-guided aspirations of sm all deep-seated sarcom a are recom m ended to ensure that the needle is within the tum our.
As soft tissue sarcom as are relatively rare tum ours (in Sw eden the annual incidence is 2± 3/10 6 inhabi- (Table 2) .
O ne challenge for the cytopathologist is the typediagnosis of high-grade deep-seated sarcoma that are candidates for preoperative radiotherapy. W hen the therapy is successful it m ight be dif® cult to diagnose reliably the histogenetic type on the surgical sam ple. Im m unocytochemistry m ay be helpful in suggesting sm ooth muscle or Schwann cell differentiation, but desm in positivity m ay be patchy in pleom orphic leiom yosarcom a and m any m alignant peripheral nerve sheet tumours do not react with the anti S-100 protein antibody. Im m unocytochem istry is, however, of help in the differential diagnosis of soft tissue carcinom a m etastases and soft tissue anaplastic large cell lym phom a versus pleom orphic sarcom a. Electron m icroscopic exam ination of aspirated m aterial is a valuable diagnostic adjunct in pleom orphic leiomyosarcom a and to certify a diagnosis of round cell or pleom orphic liposarcom a. T he diagnosis of monophasic synovial sarcom a is a wellknown problem in FN A cytodiagnosis, but we have had the decisive help of electron m icroscopic studies in a num ber of cases. 22 D N A-ploidy analysis is a lim ited but valuable adjunct. An unequivocal non-diploid cell population is com patible w ith m alignancy and according to our experience high-grade sarcom a. 31 The sm all round cell sarcom as are safe ly diagnosed by the com bined evaluation of the cytologic features and ancillary diagnostics. W ith the aid of im m unocytochem ical staining and ultrastructural investigations rhabdom yosarcom a, extraskeletal Ewing' s sarcom a and PN ET are con® dently diagnosed. D esm in, C D 99 (M IC 2 -antigen), neuron-speci® c enolase and chrom ogranin are valuable antibodies in the type-diagnosis of these tum ours. Cytogenetic and molecular genetic analyses have emerged as powerful diagnostic tools in those sarcom a where diagnostic translocations have been described and the genes involved identi® ed. T he use of cytogenetics in the diagnosis is docum ented in Ewing' s sarcoma and synovial sarcom a 32, 33 and it should be possible to m ake use of the know n molecular genetic aberrations in the diagnosis of liposarcom as with a com ponent of myxoid liposarcom a and alveolar rhabdom yosarcom a. W e have recently used RT-PCR for the diagnosis of the PCR for the diagnosis of the SSX1/SYT fusion genes in a case of suspected synovial sarcom a.
The bene® ts of FN A in the de® nitive diagnosis of soft tissue sarcom a outweigh the lim itations when (i) there is a close co-operation between cytopathologist and surgeon (referral of patients to m ultidisciplinary centres), (ii) the diagnosis is based on reliable and reproducible criteria, (iii) ancillary m ethods are part of the diagnosis and (iv) the diagnostic pitfalls are identi® ed.
